Distinctive natural history in hepatitis C virus positive diffuse large B-cell lymphoma: Analysis of 156 patients from northern Italy

Annals of Oncology

Volumn 17, Issue 9, 2006, Pages 1434-1440

  Visco, Carlo ^a   Arcaini, L ^c   Brusamolino, E ^c   Burcheri, S ^c   Ambrosetti, A ^b   Merli, M ^c   Bonoldi, E ^a   Chilosi, M ^b   Viglio, A ^c   Lazzarino, M ^c   Pizzolo, G ^b   Rodeghiero, F ^a  

^a SAN BORTOLO HOSPITAL   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

^c UNIVERSITY OF PAVIA   (Italy)

Author keywords

Diffuse large B cell lymphoma; HBV; HCV; Hepatitis; Spleen

Indexed keywords

ANTHRACYCLINE DERIVATIVE; ANTINEOPLASTIC AGENT; BLEOMYCIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; MITOXANTRONE; PREDNISONE; RITUXIMAB; VINCRISTINE;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CANCER GRADING; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DRUG TOLERABILITY; FEMALE; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; ITALY; LARGE CELL LYMPHOMA; LIVER DYSFUNCTION; LIVER METASTASIS; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; SPLEEN DISEASE; SUPERINFECTION; VISCERAL METASTASIS;

ADULT; AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; FEMALE; HEPACIVIRUS; HEPATITIS C; HUMANS; IMMUNOHISTOCHEMISTRY; ITALY; LYMPHOMA, B-CELL; LYMPHOMA, LARGE B-CELL, DIFFUSE; LYMPHOMA, LARGE-CELL, DIFFUSE; MALE; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 33748744162     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdl131     Document Type: Article

References (31)

1. Pioltelli P, Zehender G, Monti G et al. HCV and non-Hodgkyn's lymphoma. Lancet 1996; 347: 624.
2. Mele A, Pulsoni A, Bianco E et al. Hepatitis C virus and B-cell non-Hodgkin lymphomas: An Italian multicenter case-control study. Blood 2003; 102: 996-999.
3. Luppi M, Longo G, Ferrari MG et al. Clinicopathological characterization of hepatitis C virus-related B-cell non-Hodgkin's lymphomas without symptomatic cryoglobulinemia. Ann Oncol 1998; 9: 495-498.
4. Zuckermann E, Zuckermann T, Levine A et al. Hepatitis C virus infection in patients with B-cell non-Hodgkin lymphoma. Ann Intern Med 1997; 127: 423-428.
5. De Vita S, Sacco C, Sansonno D et al. Characterization of overt B-cell lymphomas in patients with Hepatitis C virus infection. Blood 1997; 90: 776-782.
6. Izumi T, Takase S. B-cell malignancy and hepatitis C virus infection. Leukemia 1997; 11: 516-518.
7. Rabkin CS, Tess BH, Christianson RE et al. Prospective study of hepatitis C viral infection as a risk factor for subsequent B-cell neoplasia. Blood 2002; 99: 4240-4242.
8. Hanley J, Jarvis L, Simmonds P et al. HCV and non-Hodgkin's lymphoma. Lancet 1996; 347: 1339.
9. McColl MD, Tait Campbell R. Hepatitis C virus infection in patients with lymphoproliferative disorders. Br J Hematol 1996; 92: 766-771.
10. Quinn ER, Chan CH, Hadlock KG et al. The B-cell receptor of a hepatitis C virus (HCV)-associated non-Hodgkin lymphoma binds the viral E2 envelope protein, implicating HCV in lymphomagenesis. Blood 2001; 98: 3745-3749.
11. Sung VM, Shimodaira S, Doughty AL et al. Establishment of B-cell lymphoma cell lines persistently infected with hepatitis C virus in vivo and in vitro: The apoptotic effects of virus infection. J Virol 2003; 77: 2134-2146.
12. Zignego AL, Ferri C, Giannelli F et al. Prevalence of bcl-2 rearrangement in patients with hepatitis C virus-related mixed cryoglobulinemia with or without B-cell lymphomas. Ann Intern Med 2002; 137: 571-580.
13. Zuckerman E, Zuckerman T, Sahar D et al. The effect of antiviral therapy on t(14;18) translocation and immunoglobulin gene rearrangement in patients with chronic hepatitis C virus infection. Blood 2001; 97: 1555-1559.
14. Casato M, Mecucci C, Agnello V et al. Regression of lymphoproliferative disorder after treatment for hepatitis C virus infection in a patient with partial trisomy 3, Bcl-2 overexpression, and type II cryoglobulinemia. Blood 2002; 99: 2259-2261.
15. Hermine O, Lefrere F, Bronowicki JP et al. Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. N Engl J Med 2002; 347: 89-94.
16. Vallisa D, Bernuzzi P, Arcaini L et al. Role of anti-hepatitis C virus (HCV) treatment in HCV-related, low-grade, B-cell, non-Hodgkin's lymphoma: A multicenter Italian experience. J Clin Oncol 2005; 23: 468-473.
17. Giannelli F, Moscarella S, Giannini C et al. Effect of antiviral treatment in patients with chronic HCV infection and t(14;18) translocation. Blood 2003; 102: 1196-1201.
18. Besson C, Canioni D, Lepage E et al. Characteristics and outcome of diffuse large B-cell lymphoma in hepatitis C virus-positive in LNH 93 and LNH 98 groupe d'etude des lymphomas de l'adulte programs. J Clin Oncol 2006; 24: 953-960.
19. Bellentani S, Tiribelli C, Saccoccio G et al. Prevalence of chronic liver desease in the general population of northern Italy the Dionysos study. Hepatology 1994; 20: 1442-1449.
20. Carbone PP, Kaplan HS, Musshoff K et al. Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res 1971; 31: 1860-1861.
21. Isaacson PG. Gastrointestinal lymphoma. Hum Pathol 1994; 25: 1020-1029.
22. Hans CP, Weisenburger DD, Greiner TC et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 2004; 103: 275-282.
23. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med 1993; 329: 987-994.
24. Visco C, Medeiros LJ, Jones D et al. Primary cutaneous non Hodgkin's lymphoma with aggressive histology: Inferior outcome is associated with peripheral T-cell type and elevated lactate dehydrogenase, but not extent of cutaneous involvement. Ann Oncol 2002; 13: 1290-1299.
25. Golioto M, McGrath K. Primary lymphoma of the esophagus in a chronically immunosuppressed patient with hepatitis C infection: Case report and review of the literature. Am J Med Sci 2001; 321: 203-205.
26. Longo G, Potenza L, D'Apollo N et al. Unusual sites of malignancy: Case 1. Primary non-Hodgkin's lymphoma of the hand in a patient with hepatitis C infection. J Clin Oncol 2001; 19: 1570-1572.
27. Zuckerman E, Zuckerman T, Douer D et al. Liver dysfunction in patients infected with hepatitis C virus undergoing chemotherapy for hematologic malignancies. Cancer 1998; 83: 1224-1230.
28. Takai S, Tsurumi H, Ando K et al. Prevalence of hepatitis B and C virus infection in haematological malignancies and liver injury following chemotherapy. Eur J Haematol 2005; 74: 158-165.
29. Zaja F, De Vita S, Mazzaro C et al. Efficacy and safety of rituximab in type II mixed cryoglobulinemia. Blood 2003; 101: 3827-3834.
30. Tomita N, Kodama F, Takabayashi M et al. Clinical features and outcome in HCV-positive aggressive non-Hodgkin's lymphoma. Leuk Lymphoma 2003; 44: 1159-1164.
31. Iannitto E, Ammatuna E, Tripodo C et al. Long-lasting remission of primary hepatic lymphoma and hepatitis C virus infection achieved by the alpha-interferon treatment. Hematol J 2004; 5: 530-533.